From the Journals

Baby boomers account for more than 74% of chronic HCV cases


 

FROM THE JOURNAL OF INFECTION AND PUBLIC HEALTH

The overall prevalence of chronic hepatitis C virus (HCV) in the United States was 1.19%, giving an estimate of 2,347,852 infected adults. Baby boomers had the highest prevalence at 2.23%, accounting for more than 74% of all chronic HCV cases, according to the results of a database analysis done by Kevin J. Moore, MD, of the University of Miami and his colleagues.

A binder label reads "Diagnosis: hepatitis" ©vchal/Thinkstock

In the analysis, published in the Journal of Infection and Public Health, the researchers assessed data from National Health and Nutrition Examination Survey for the years 1999-2012. They separated three age categories: baby boomers (BB), younger than BB (YG), and older than BB (OG). BBs showed an HCV prevalence over four times higher than YG or OG. BBs also had more significant predictors of positive HCV status than YGs or OGs.

In addition to the overall difference in incidence of HCV infection in boomers and nonboomers, they found that significant predictors of chronic HCV positivity among BBs were being male or non-Hispanic black, having a positive blood transfusion history, being a current or former smoker, and living below the poverty line.

The most significant risk factor for HCV positivity differed across age groups – being a current smoker in YG and BB and being non-Hispanic black in OG, the researchers noted.

“These results show that HCV infection continues to be a significant public health issue and warrants further attention given the aging BB population. Future studies should seek to further identify age-specific risk factors for HCV infection to optimize HCV screening and prevention programs through public health interventions,” the researchers concluded.

The authors reported that they had no conflicts of interest.

SOURCE: Moore KJ et al. J Infect Public Health. 2019 Jan-Feb;12(1):32-6.

Recommended Reading

HCV infection tied to premature ovarian senescence and a high miscarriage rate
Journal of Clinical Outcomes Management
AGA Clinical Practice Update: Statins are safe, effective, and important for most patients with liver disease and dyslipidemia
Journal of Clinical Outcomes Management
National Academies issues 5-step plan to address infections linked to opioid use disorder
Journal of Clinical Outcomes Management
Automated algorithm improves HIV/HCV screening in the ED
Journal of Clinical Outcomes Management
ACIP supports hepatitis A vaccine for homeless individuals
Journal of Clinical Outcomes Management
ACIP votes unanimously in favor of immunization schedule update and redesign
Journal of Clinical Outcomes Management
Struggling to reach an HCV vaccine
Journal of Clinical Outcomes Management
U.S. death rates from chronic liver disease continue to rise
Journal of Clinical Outcomes Management
It’s time for universal HCV screening in the ED
Journal of Clinical Outcomes Management
Chronic infections such as HCV, HIV, and TB cause unique problems for psoriasis patients
Journal of Clinical Outcomes Management